These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 19148581

  • 21. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH, de Vries EG, Meersma GJ, Hougardy BM, van der Zee AG, de Jong S.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):543-52. PubMed ID: 18793956
    [Abstract] [Full Text] [Related]

  • 22. TRAIL enhances apoptosis of human hepatocellular carcinoma cells sensitized by hepatitis C virus infection: therapeutic implications.
    Jang JY, Kim SJ, Cho EK, Jeong SW, Park EJ, Lee WC, Lee SH, Kim SG, Kim YS, Kim HS, Kim BS, Lin W, Chung RT.
    PLoS One; 2014 Oct 01; 9(6):e98171. PubMed ID: 24927176
    [Abstract] [Full Text] [Related]

  • 23. Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma.
    Zuzak TJ, Steinhoff DF, Sutton LN, Phillips PC, Eggert A, Grotzer MA.
    Eur J Cancer; 2002 Jan 01; 38(1):83-91. PubMed ID: 11750844
    [Abstract] [Full Text] [Related]

  • 24. N-Acetyl-Glucosamine Sensitizes Non-Small Cell Lung Cancer Cells to TRAIL-Induced Apoptosis by Activating Death Receptor 5.
    Liang Y, Xu W, Liu S, Chi J, Zhang J, Sui A, Wang L, Liang Z, Li D, Chen Y, Niu H.
    Cell Physiol Biochem; 2018 Jan 01; 45(5):2054-2070. PubMed ID: 29533936
    [Abstract] [Full Text] [Related]

  • 25. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
    Das S, Tripathi N, Preet R, Siddharth S, Nayak A, Bharatam PV, Kundu CN.
    Oncotarget; 2017 Jan 03; 8(1):248-267. PubMed ID: 27542249
    [Abstract] [Full Text] [Related]

  • 26. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.
    Zhang X, Inukai T, Hirose K, Akahane K, Kuroda I, Honna-Oshiro H, Kagami K, Goi K, Nakamura K, Kobayashi M, Endo M, Yagita H, Kurosawa H, Thomas Look A, Honda H, Inaba T, Nakazawa S, Sugita K.
    Leukemia; 2012 Dec 03; 26(12):2483-93. PubMed ID: 22743623
    [Abstract] [Full Text] [Related]

  • 27. Death receptor 5 is activated by fucosylation in colon cancer cells.
    Zhang B, van Roosmalen IAM, Reis CR, Setroikromo R, Quax WJ.
    FEBS J; 2019 Feb 03; 286(3):555-571. PubMed ID: 30589515
    [Abstract] [Full Text] [Related]

  • 28. Tetrandrine (TET) Induces Death Receptors Apo Trail R1 (DR4) and Apo Trail R2 (DR5) and Sensitizes Prostate Cancer Cells to TRAIL-Induced Apoptosis.
    Shishodia G, Koul S, Dong Q, Koul HK.
    Mol Cancer Ther; 2018 Jun 03; 17(6):1217-1228. PubMed ID: 29549167
    [Abstract] [Full Text] [Related]

  • 29. Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells.
    Shlyakhtina Y, Pavet V, Gronemeyer H.
    Cell Death Dis; 2017 Aug 31; 8(8):e3025. PubMed ID: 29048428
    [Abstract] [Full Text] [Related]

  • 30. DR4-Ser424 O-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death.
    Lee H, Oh Y, Jeon YJ, Lee SY, Kim H, Lee HJ, Jung YK.
    Cancer Res; 2019 Jun 01; 79(11):2839-2852. PubMed ID: 30987996
    [Abstract] [Full Text] [Related]

  • 31. Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway.
    Vondálová Blanárová O, Jelínková I, Szöor A, Skender B, Soucek K, Horváth V, Vaculová A, Andera L, Sova P, Szöllosi J, Hofmanová J, Vereb G, Kozubík A.
    Carcinogenesis; 2011 Jan 01; 32(1):42-51. PubMed ID: 21037225
    [Abstract] [Full Text] [Related]

  • 32. Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway.
    Cha Z, Cheng J, Xiang H, Qin J, He Y, Peng Z, Jia J, Yu H.
    Cancer Chemother Pharmacol; 2019 Oct 01; 84(4):719-728. PubMed ID: 31281953
    [Abstract] [Full Text] [Related]

  • 33. GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis.
    Kurita S, Mott JL, Almada LL, Bronk SF, Werneburg NW, Sun SY, Roberts LR, Fernandez-Zapico ME, Gores GJ.
    Oncogene; 2010 Aug 26; 29(34):4848-58. PubMed ID: 20562908
    [Abstract] [Full Text] [Related]

  • 34. Capsaicin sensitizes TRAIL-induced apoptosis through Sp1-mediated DR5 up-regulation: involvement of Ca(2+) influx.
    Moon DO, Kang CH, Kang SH, Choi YH, Hyun JW, Chang WY, Kang HK, Koh YS, Maeng YH, Kim YR, Kim GY.
    Toxicol Appl Pharmacol; 2012 Feb 15; 259(1):87-95. PubMed ID: 22200406
    [Abstract] [Full Text] [Related]

  • 35. A novel TRAIL mutant-TRAIL-Mu3 enhances the antitumor effects by the increased affinity and the up-expression of DR5 in pancreatic cancer.
    Huang M, Zhu H, Yi C, Yan J, Wei L, Yang X, Chen S, Huang Y.
    Cancer Chemother Pharmacol; 2018 Nov 15; 82(5):829-838. PubMed ID: 30167846
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. An HPLC method associated with a thermodynamic analysis to compare the binding of TRAIL and its nanovectorized form to death receptors DR4 and DR5 and their relationship to cytotoxicity.
    Guillaume YC, Lethier L, André C.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov 15; 1036-1037():142-148. PubMed ID: 27750195
    [Abstract] [Full Text] [Related]

  • 39. 5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells.
    Xie ZH, Quan MF, Liu F, Cao JG, Zhang JS.
    BMC Cancer; 2011 Jul 29; 11():322. PubMed ID: 21801359
    [Abstract] [Full Text] [Related]

  • 40. Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction.
    Zhou L, Wang W, Dicker DT, Humphreys RC, El-Deiry WS.
    Cancer Biol Ther; 2011 Aug 15; 12(4):335-48. PubMed ID: 21785270
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.